A study by Chen et al. demonstrated that STIM1 is able to control the production of vascular endothelial growth factor (VEGF) in cervical cancer by inhibiting STIM1, and the ability to govern the growth of blood vessels and tumours could be impaired [62]. This evidence concerns the gene VEGFA and cervical carcinoma.